tiprankstipranks
Neurocrine price target raised to $106 from $100 at Piper Sandler
PremiumThe FlyNeurocrine price target raised to $106 from $100 at Piper Sandler
3M ago
Neumora Therapeutics appoints Panandiker as Chief Commercial Officer
PremiumThe Fly
Neumora Therapeutics appoints Panandiker as Chief Commercial Officer
3M ago
Cerevel Therapeutics price target raised to $45 from $25 at JPMorgan
PremiumThe Fly
Cerevel Therapeutics price target raised to $45 from $25 at JPMorgan
4M ago
Cerevel Therapeutics just downgraded at Stifel, here’s why
PremiumThe FlyCerevel Therapeutics just downgraded at Stifel, here’s why
4M ago
Cerevel Therapeutics downgraded to Hold from Buy at Stifel
PremiumThe Fly
Cerevel Therapeutics downgraded to Hold from Buy at Stifel
4M ago
The biopharma stocks to own in 2024, according to Morgan Stanley
PremiumThe Fly
The biopharma stocks to own in 2024, according to Morgan Stanley
4M ago
Cerevel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe FlyCerevel Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
5M ago
After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next
PremiumThe Fly
After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next
5M ago
After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next
PremiumThe Fly
After AbbVie agrees to buy Cerevel, analysts weigh in on who may be next
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100